Stamford, CT -- (SBWIRE) -- 01/27/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Uroplasty, Inc. (NASDAQ:UPI), LiveDeal Inc (NASDAQ:LIVE), Generex Biotechnology Corporation (OTCMKTS:GNBT), Inuvo, Inc. (NYSEMKT:INUV)
Uroplasty, Inc. (NASDAQ:UPI) opened the session at $3.75, trading in a range of $3.75 - $5.40. The stock showed a positive performance of +28.29% in the last trading session from its previous close of $3.50 and closed at $4.49. The stock traded on a volume of 2.07 million shares and the average volume of the stock remained 106,596 shares. Uroplasty, Inc. is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Company’s primary focus is on two products: the Urgent PC Neuromodulation system and Macroplastique Implants.
For How Long UPI will Fight for Profitability? Read This Trend Analysis report
LiveDeal Inc (NASDAQ:LIVE) traded 2.65 million shares in the last business day while the average volume of the stock remained 525,194 shares. The stock showed a positive movement of +24.59% to end at $21.18. The 52 week range of the stock remained $1.97 - $25.10. LiveDeal, Inc. provides web-based local customer acquisition and related products for small and local businesses. The Company's website is ideal for trading hard-to-ship items such as automobiles, furniture, pets, appliances, real estate and other "try before you buy" items, eliminating shipping costs and reducing fraud.
For How Long LIVE’s Gloss will Attract Investors? Find out via this report
Generex Biotechnology Corporation (OTCMKTS:GNBT) reported 274.43 million shares were exchanged during the last trade, while the average volume is about 106,596 shares. The stock escalated +28.29% and finished the day at $4.49. The beta of the stock is recorded at 0.28. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world.
For How Long GNBT’s Gloss will Attract Investors? Find out via this report
Inuvo, Inc. (NYSEMKT:INUV) shares rose, +14.73 percent from its previous close of $1.29 to close at $1.48. Traded with volume of 2.24 million shares in the prior session and the average volume of the stock remained 194,686 shares. Inuvo, Inc. develops software and analytics technology that is accessible over the Internet for use by online advertisers and Website publishers. The Company's platforms provide a mechanism for advertisers, publishers and consumers to easily and openly connect, thus facilitating the execution of marketing programs.
Why Should Investors Buy INUV After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)